Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak
Viruses · 2025
DOI: 10.3390/v17111410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Raymond Ernest Kaweesa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Uganda Virus Research Institute, Entebbe, Uganda. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Ebola, Survivors, Disease Outbreaks, Ebolavirus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CEPI, Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
Background
Despite repeated re-emergence of Sudan ebolavirus (SUDV), its long-term human toll remains under-characterised. We assessed multisystem clinical, biochemical, and psychosocial outcomes ~25 years after the 2000 Gulu outbreak.
Methods
We conducted a cross-sectional evaluation of 45 survivors of laboratory-confirmed SUDV and 30 age- and gender-matched community controls from the same region. Symptoms were assessed as current at the study visit using a structured checklist; for each symptom present, we recorded severity and duration from onset to the visit date. Standardised clinical examinations, haematological and biochemical assessments, anxiety and depression screening, and structured interviews on social support and stigma were performed. Group comparisons were assessed with Wilcoxon rank-sum and χ2/Fisher’s exact tests; correlations were assessed with Spearman’s ρ.
Findings
Core physiological indices (vital signs, BMI, blood pressure, and body temperature) and mental health were comparable between survivors and controls. Nevertheless, survivors reported ongoing symptoms, including joint pain and visual impairment each in 36% (16/45), fatigue in 18% (8/45), and neurological symptoms in 13% (6/45). Subclinical laboratory deviations centred on hepatic and platelet biology: elevated total bilirubin occurred in 14% of survivors versus 6.7% of controls; thrombocytopenia or platelet morphological abnormalities in 12% versus 3.3%; haemoglobin abnormalities in 6% versus 0%. Among survivors, albumin and mean platelet volume declined with age (both p ≤ 0.03). Psychological morbidity was low (normal anxiety 82% (37/45; and normal depression 80% (36/45). Yet a social paradox emerged, despite universal post-outbreak support, 98% (44/45) described enduring stigma. To minimise differential recall bias, symptom inventories were not collected from controls; consequently, between-group comparisons for symptom prevalence were not performed, and symptom inferences are restricted to survivors and framed descriptively.
Interpretation
A quarter-century after infection, SUDV survivors show preserved systemic physiology but carry chronic musculoskeletal, sensory, and neurological sequelae, alongside a discrete subclinical profile implicating hepatic function and platelet biology. Psychological resilience coexists with near-universal, persistent stigma, indicating that material support did not achieve full psychosocial reintegration. Given the lack of virological and deep immune profiling, proposed pathogenetic mechanisms, such as antigen persistence or immune-mediated injury, remain speculative and hypotheses-generating only. These findings argue for survivor-centred long-term care, embedded with epidemic preparedness frameworks that integrate musculoskeletal rehabilitation, ophthalmic and neurological services with comprehensive mental health care, and sustained anti-stigma community engagement. This dissociation, including short-lived support alongside enduring stigma, indicates that humanitarian relief alone does not secure durable psychosocial reintegration and should be complemented by long-horizon, survivor-centred services and community engagement. Funding: This study was supported by the Coalition for Epidemic Preparedness Innovations (CEPI) under the Universal Protocol for Standardising Assays and Advancing Vaccine Immunogenicity Assessments for Emerging and Re-emerging Viral Threats, implemented through the Uganda Virus Research Institute (UVRI) as part of CEPI’s Centralised Laboratory Network (CLN).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Uganda Virus Research Institute, Entebbe, Uganda.
- Medical Research Council/Uganda Virus Research Institute & London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Research Unit, Entebbe, Uganda.
ORCID-Profile: Raymond Ernest Kaweesa, Joseph Ssebwana Katende, Raymond Reuel Wayesu, Jennifer Serwanga
Förderung
- CEPI
- Coalition for Epidemic Preparedness Innovations
- Bill & Melinda Gates Foundation
Zitieren
APA
Kaweesa, R. E., Katende, J. S., Odoch, G., Ntabadde, A. D., Wayesu, R. R., Mukisa, D., Ejou, P., On Behalf Of The FiloStudy Team, Kaleebu, P., & Serwanga, J. (2025). Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak. Viruses. https://doi.org/10.3390/v17111410
Vancouver
Kaweesa RE, Katende JS, Odoch G, Ntabadde AD, Wayesu RR, Mukisa D, et al. Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak. Viruses. 2025. doi:10.3390/v17111410
BibTeX
@article{Kaweesa2025,
author = {Kaweesa, Raymond Ernest and Katende, Joseph Ssebwana and Odoch, Geoffrey and Ntabadde, Annie Daphine and Wayesu, Raymond Reuel and Mukisa, Deborah and Ejou, Peter and On Behalf Of The FiloStudy Team and Kaleebu, Pontiano and Serwanga, Jennifer},
title = {Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17111410}
}
EUVIMED